COVID-19 vaccine expert in UAE explains efficacy of Sinopharm jab, booster dose ...United Arab Emirates

Khaleej Times - News
COVID-19 vaccine expert in UAE explains efficacy of Sinopharm jab, booster dose
Dubai: During the peak of the pandemic, G42 Healthcare, a home-grown, Abu Dhabi-based company, facilitated the 4Humanity project that involved the world’s first ever Phase III clinical trials of a deactivated vaccine against COVID-19 - Sinopharm. Over 43,000 volunteers participated in the pan-Arab Phase III trial from over 125 nationalities. This actually set the stage for the rollout of the vaccine in the community. The World Health Organisation (WHO) granted it approval for emergency use last month. As the Arab Health Congress 2021 begins, Gulf News spoke to Dr Walid Zaher, Chief Research Officer and Vaccine Project Leader at G42, to gain an insight into his experience of managing the his

Read More Details
Finally We wish PressBee provided you with enough information of ( COVID-19 vaccine expert in UAE explains efficacy of Sinopharm jab, booster dose )

Also on site :



Latest News